{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:48:48Z","timestamp":1790696928434,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.041","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:02:15Z","timestamp":1496016135000},"page":"3655-3660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Maternal Tdap vaccination and risk of infant morbidity"],"prefix":"10.1016","volume":"35","author":[{"given":"Malini","family":"DeSilva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Vazquez-Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S.","family":"Lipkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Craig","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Hambidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse O.","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2017.05.041_b0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/650460","article-title":"2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia","volume":"50","author":"Hewagama","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2017.05.041_b0010","first-page":"1424","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.041_b0015","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2013Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.041_b0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2017.05.041_b0025","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.05.041_b0030","doi-asserted-by":"crossref","unstructured":"Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 2013; 163(5): 1422\u20131426 e1421\u20131424.","DOI":"10.1016\/j.jpeds.2013.06.021"},{"issue":"17","key":"10.1016\/j.vaccine.2017.05.041_b0035","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.05.041_b0040","doi-asserted-by":"crossref","unstructured":"Zheteyeva YA, Moro PL, Tepper NK, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(1): 59 e51\u201357.","DOI":"10.1016\/j.ajog.2012.05.006"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.041_b0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.041_b0050","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1080\/21645515.2015.1072664","article-title":"The centers for disease control and prevention's public health response to monitoring Tdap safety in pregnant women in the United States","volume":"11","author":"Moro","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.041_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00001432-200206000-00014","article-title":"Sequelae of chorioamnionitis","volume":"15","author":"Hagberg","year":"2002","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.041_b0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita","year":"2010","journal-title":"Clin Perinatol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.041_b0065","first-page":"11","article-title":"The association of chorioamnionitis with preterm delivery","volume":"65","author":"Guzick","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.041_b0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0029-7844(95)00402-5","article-title":"Risk factors for neonatal sepsis","volume":"87","author":"Yancey","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.05.041_b0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/14767058.2012.664447","article-title":"Inflammation-induced immune suppression of the fetus: a potential link between chorioamnionitis and postnatal early onset sepsis","volume":"25","author":"Wolfs","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.041_b0080","first-page":"274","article-title":"Chorioamnionitis and the prognosis for term infants","volume":"94","author":"Alexander","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.05.041_b0085","doi-asserted-by":"crossref","unstructured":"Soraisham AS, Singhal N, McMillan DD, Sauve RS, Lee SK, Canadian Neonatal N. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol 2009; 200(4): 372 e371\u2013376.","DOI":"10.1016\/j.ajog.2008.11.034"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.041_b0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1542\/peds.97.2.210","article-title":"Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops","volume":"97","author":"Watterberg","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.05.041_b0095","doi-asserted-by":"crossref","unstructured":"Been JV, Rours IG, Kornelisse RF, et al. Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol 2009; 201(6): 587 e581\u2013588.","DOI":"10.1016\/j.ajog.2009.06.025"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.041_b0100","doi-asserted-by":"crossref","first-page":"e81193","DOI":"10.1371\/journal.pone.0081193","article-title":"Chorioamnionitis and subsequent lung function in preterm infants","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS One"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2017.05.041_b0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.105.1.8","article-title":"Intrapartum maternal fever and neonatal outcome","volume":"105","author":"Lieberman","year":"2000","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.041_b0110","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/21645515.2016.1157241","article-title":"Maternal and infant outcomes among women vaccinated against pertussis during pregnancy","volume":"12","author":"Berenson","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.041_b0115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.05.041_b0120","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"27","key":"10.1016\/j.vaccine.2017.05.041_b0125","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.vaccine.2013.03.069","article-title":"Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink","volume":"31","author":"Naleway","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.041_b0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2014.05.025","article-title":"Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites","volume":"67","author":"Kharbanda","year":"2014","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.041_b0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/AOG.0b013e3182a1118a","article-title":"Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events","volume":"122","author":"Kharbanda","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3 Suppl","key":"10.1016\/j.vaccine.2017.05.041_b0140","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ajog.2012.06.073","article-title":"Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink","volume":"207","author":"Kharbanda","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.05.041_b0145","doi-asserted-by":"crossref","unstructured":"Nordin JD, Kharbanda EO, Vazquez Benitez G, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014; 164(5): 1051\u20131057 e1052.","DOI":"10.1016\/j.jpeds.2014.01.037"},{"key":"10.1016\/j.vaccine.2017.05.041_b0150","doi-asserted-by":"crossref","unstructured":"Bastek JA, Weber AL, McShea MA, Ryan ME, Elovitz MA. Prenatal inflammation is associated with adverse neonatal outcomes. Am J Obstet Gynecol 2014; 210(5): 450 e451\u2013410.","DOI":"10.1016\/j.ajog.2013.12.024"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.041_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-0528.1995.tb09060.x","article-title":"Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section","volume":"102","author":"Morrison","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.041_b0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1651-2227.2004.tb02990.x","article-title":"Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery","volume":"93","author":"Zanardo","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2017.05.041_b0165","doi-asserted-by":"crossref","unstructured":"Consortium on Safe Labor Hibbard J.U. Wilkins I. et al. Respiratory morbidity in late preterm births. JAMA 2010; 304(4): 419\u2013425","DOI":"10.1001\/jama.2010.1015"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.041_b0170","doi-asserted-by":"crossref","first-page":"e009536","DOI":"10.1136\/bmjopen-2015-009536","article-title":"Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study","volume":"6","author":"Walls","year":"2016","journal-title":"BMJ Open"},{"issue":"17","key":"10.1016\/j.vaccine.2017.05.041_b0175","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2016.14432","article-title":"Tdap Vaccination During Pregnancy and Microcephaly and Other Structural Birth Defects in Offspring","volume":"316","author":"DeSilva","year":"2016","journal-title":"JAMA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:41:32Z","timestamp":1659048092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306771"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal Tdap vaccination and risk of infant morbidity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}